Kayleigh Marx

Dr. Kayleigh Marx, a clinical pharmacy specialist in leukemia at MD Anderson Cancer Center, shares her expertise on venetoclax, a pivotal drug in leukemia treatment. She discusses the drug's intriguing history and development, including its approval for chronic lymphocytic and acute myeloid leukemia. Dr. Marx delves into the pharmacological mechanisms behind venetoclax and its effectiveness, while addressing the significant toxicities and challenges in patient care. Insightful tips on individualized dosing and the role of pharmacists in optimizing treatment are also explored.